Chrysophanol targets significantly decrease blood lipids, serum insulin levels in diabetes, and reduces inflammatory cytokines, myocardial enzymes creatine kinase (CK) and lactate dehydrogenase (LDH), and increases SIRT1 protein expression. Here, INS is linked to diabetes mellitus.